掌握事實 · 自殺迷思
自殺嘅威脅，係行動派醫生、政客同醫療機構多年嚟用嚟為兒童變性買支持嘅頭號手段。
父母甚至被人講，佢哋可以有一個死咗嘅女，或者一個活嘅仔。呢個係脅迫式操控，亦係一個卑鄙嘅謊言。
事實已經清楚。自殺身亡幸好好少見，同埋未有證據顯示兒童醫學變性可以防止自殺。
睇圖，唔好睇一牆連結。青少年研究唔係成人研究。自殺企圖嘅問卷調查唔係自殺死亡嘅計數。
News — Supreme Court exchange
In U.S. v. Skrmetti oral argument (Dec 4, 2024), ACLU attorney Chase Strangio told Justice Alito there is no evidence in the studies that gender-affirming treatment reduces completed suicide, and that completed suicide is “thankfully and admittedly” rare — while distinguishing that from “suicidality.”
來自 Biggs (2022)、Van Cauwenberg (2021)、Ruuska (2024)、Do No Harm、Cass、HHS 同 Dhejne 2011 嘅自殺相關發現
研究
Tavistock GIDS referrals, 2010–2020.
發現
Among ~15,032 youth referred to Tavistock GIDS (2010–2020), 4 suicides — completed suicide rare in absolute terms (HHS Table 4.1: 0.03%, 0.13 per 1K patient-years).
研究
Belgian pediatric gender clinic cohort.
發現
Belgian pediatric gender clinic cohort; 5 suicides among referred youths (HHS Table 4.1: 3.38%, 11.26 per 1K patient-years); HHS notes all suicides among patients taking cross-sex hormones.
研究
Youth and young adults under 23 referred to Finnish gender services, 1996–2019: 2,083 people vs 16,643 matched controls.
發現
Suicide deaths were uncommon (0.3% vs 0.1% in matched peers) and, once specialist psychiatric treatment was accounted for, not statistically different; medical gender reassignment was not shown to change suicide risk.
研究
New — 17 September 2026
CDC teen suicide rates after state bans on puberty blockers, opposite-sex hormones, and surgeries for minors. Jay Greene, Ph.D. and Ian Kingsbury, Ph.D. for Do No Harm. Three models: difference-in-differences, Callaway–Sant’Anna DiD, and a national time-series.
發現
Do No Harm analyzed CDC teen suicide rates after state bans on puberty blockers, opposite-sex hormones, and surgeries for minors. Across three models (difference-in-differences, Callaway–Sant’Anna DiD, and a national time-series), there was no statistically significant increase in teen suicide rates. The claim that these bans cause a spike in teen suicides is not supported by the data.
研究
Independent review of NHS gender identity services for children and young people, underpinned by University of York systematic reviews.
發現
The evidence does not support the claim that hormone treatment reduces the elevated risk of death by suicide in this population.
研究
U.S. Department of Health and Human Services review of treatment for pediatric gender dysphoria. The suicide points on this chart are from that review.
發現
There is no evidence that pediatric medical transition reduces suicide deaths, which remain very low; completed suicide among adolescents with gender dysphoria is rare, and suicidality tracks with other mental-health conditions rather than with gender dysphoria alone.
研究
Adults. All 324 people in Sweden who had sex-reassignment surgery, 1973–2003, compared with matched population controls.
發現
After sex reassignment / surgical transition, suicide deaths were about 19.1 times higher than among matched peers (adjusted hazard ratio 19.1). Transition did not bring suicide mortality in line with the general population — the elevated suicide risk remained after transition.
舊嘅 GIDS「Evidence base」網頁已經冇咗，所以呢度唔用佢做來源。英國官方追蹤係 2024 年 Appleby 關於 Tavistock / GIDS 自殺嘅報告：數據唔支持青春期阻斷藥受限制之後自殺大幅上升。 Appleby 2024 — Tavistock / GIDS suicides (GOV.UK) →
訂閱。接收更新。
揀每日消息更新、每週匯總，或者兩個都要。